| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 03/14/2007 | CN1303974C Carrier particles for use in dry powder inhalers |
| 03/13/2007 | US7189819 Humanized antibodies that recognize beta amyloid peptide |
| 03/13/2007 | US7189712 For therapy of hyperproliferative diseases |
| 03/13/2007 | US7189420 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof |
| 03/13/2007 | US7189390 Probiotics for pet food applications |
| 03/13/2007 | CA2332474C Low etoxyl sorbitan ester based keratinous materials washing compositions |
| 03/13/2007 | CA2315227C Arylpiperazines having activity at the serotonin 1a receptor |
| 03/08/2007 | WO2005055920A3 Compositions and methods for treatment of psychiatric disorders |
| 03/08/2007 | US20070055288 Device for umbilicus protection during abdominal surgery |
| 03/08/2007 | US20070054954 Method of manufacturing glimepiride and the respective intermediate |
| 03/08/2007 | US20070054928 c-Met modulators and methods of use |
| 03/08/2007 | US20070054923 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054922 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054920 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054898 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/08/2007 | US20070054874 Methods for the selective treatment of tumors by calcium-mediated induction of apoptosis |
| 03/08/2007 | US20070054378 Elicitation of antibodies to self peptides in mice by immunization with dendritic cells |
| 03/08/2007 | US20070054361 Compositions and methods for the diagnosis and treatment of tumor |
| 03/08/2007 | US20070053979 Controlled release formulation of erythromycin derivatives |
| 03/08/2007 | US20070053911 Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2) |
| 03/08/2007 | US20070053843 Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same |
| 03/07/2007 | EP1759013A2 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 03/07/2007 | EP1758540A1 Purification of insulin-like material by reverse phase chromatography |
| 03/07/2007 | EP1047390B1 Dual component antiplaque dentifrice composition |
| 03/07/2007 | CN1926132A Pyrazole compounds useful as protein kinase inhibitors |
| 03/07/2007 | CN1923835A Polymorphs of clopidogrel hydrogensulfate |
| 03/06/2007 | US7186860 Esterification of 2-[(diphenylmethyl)thio]acetic acid with an acyclic alcohol under reflux in the presence of an acid catalyst; amidation with ammonia; further oxidation with hydrogen peroxide produces Modafinil; central nervous system stimulant; narcolepsy |
| 03/06/2007 | US7186699 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes |
| 03/06/2007 | US7186401 comprises magnesium stearate for improved storage stability; inhalers |
| 03/06/2007 | CA2277913C New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 03/06/2007 | CA2202228C Novel retinoids |
| 03/01/2007 | WO2005011610A3 Neurodegenerative protein aggregation inhibition methods and compounds |
| 03/01/2007 | WO2004105697A3 Novel lipids for transfection of nucleic acids |
| 03/01/2007 | WO2004084806A3 Protein modification and maintenance molecules |
| 03/01/2007 | US20070049600 Pteridinones as kinase inhibitors |
| 03/01/2007 | US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors |
| 03/01/2007 | US20070048301 Compositions and methods for the treatment of immune related diseases |
| 02/28/2007 | EP1757696A2 Group B streptococcus proteins, and their use |
| 02/28/2007 | EP1757601A1 Quinoline derivatives and their use in glaucoma and myopia |
| 02/28/2007 | EP1476535A4 Stenoprophiluric generation and isolation of chemical products |
| 02/28/2007 | EP1429807B1 Combination of a nsaid and a pde-4 inhibitor |
| 02/28/2007 | EP1392666B1 Biologically active methylene blue derivatives |
| 02/28/2007 | CN1922206A Process for the preparation of latent antithrombin iii |
| 02/28/2007 | CN1922199A Ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 02/28/2007 | CN1921892A Lentiviral vector delivery of msp36 for treatment of cancer |
| 02/28/2007 | CN1920050A Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
| 02/27/2007 | US7183388 Anti-MUC-1 single chain antibodies for tumor targeting |
| 02/27/2007 | US7183313 Keto cannabinoids with therapeutic indications |
| 02/27/2007 | US7183312 Compounds for use as antigrowth agents or antitumor agents and with solvents |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183270 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/27/2007 | US7183267 Bis[(dihydroxyborylphenyl)carbonyloxy]benzenes may be synergistically combined with beta-lactam antibiotics to treat beta-lactam antibiotic resistant bacterial infections |
| 02/27/2007 | US7182964 Dissolving thin film xanthone supplement |
| 02/27/2007 | US7182942 Vaccine immunotherapy for immune suppressed patients |
| 02/27/2007 | US7181799 Oral-care device and system |
| 02/22/2007 | WO2007020328A1 Cosmetic product for the treatment of scalp |
| 02/22/2007 | WO2004098491A3 METHOD OF PREVENTING INFECTIONS FROM BIOTERRORISM AGENTS WITH IMMUNOSTIMULATORY CpG OLIGONUCLEOTIDES |
| 02/22/2007 | US20070043509 Albumin binding sites for evaluating drug interactions and methods of evaluating or designing drugs based on their albumin binding properties |
| 02/22/2007 | US20070043202 Self-crosslinkable poly(caprolactone fumarate) |
| 02/22/2007 | US20070043076 Substituted 2-arylmethylene-n-aryl-n'aryl-malonamides and analogs as activators of caspases and inducers of apoptosis |
| 02/22/2007 | US20070043042 Quinoline potassium channel inhibitors |
| 02/22/2007 | US20070043039 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 02/22/2007 | US20070043015 Phenyl pyrrolidine ether tachykinin receptor antagonists |
| 02/22/2007 | US20070043014 3,5-Aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as s1p receptor agonists |
| 02/22/2007 | US20070043001 Cancer; 1-(1-{4-[5-(5-amino-1,3,4-thiadiazol-2-yl)-3-phenylpyridin-2-yl]benzyl}piperidin-4-yl) -1H-pyrazolo[3,4-d]pyrimidin-4-amine; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, enhanced pharmacokinetic properties |
| 02/22/2007 | US20070042945 Nouvelles compositions et methods de traitement du psoriasis |
| 02/22/2007 | US20070042403 Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases |
| 02/22/2007 | US20070042368 Detection and monitoring of lung cancer |
| 02/22/2007 | US20070042045 Multilayer dosage form comprising a matrix that influences release of a modulatory substance |
| 02/22/2007 | US20070041987 Fragments or polymers of albumin with tunable vascular residence time for use in therapeutic delivery and vaccine development |
| 02/22/2007 | US20070041941 Nucleic acid sequences encoding and compositions comrpising ige signal peptide and/or il-15 and methods for using the same |
| 02/22/2007 | US20070039107 For dyeing keratin fibres which are capable of giving more intense and yet unselective colorations which show good resistance to the various attacking factors to which the hair may be subjected |
| 02/21/2007 | EP1603517B1 Skin care product containing tall oil fatty acids and vegetable oils for dry and scaling skin and treatment of psoriasis, dermatitis, and eczemas |
| 02/21/2007 | EP1578369A4 Screening strategy for anticancer drugs |
| 02/21/2007 | EP1511727B1 Aromatic sulfones and their medical use |
| 02/21/2007 | EP1463576B1 Mesoporous permeation layers for use on active electronic matrix devices |
| 02/21/2007 | EP1458690B1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | CN1917896A Surface protection of exposed biological tissues |
| 02/21/2007 | CN1917874A Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method |
| 02/21/2007 | CN1916025A Analogs of parathyroid hormone |
| 02/21/2007 | CN1916009A Process for preparing amine platinum complexes |
| 02/21/2007 | CN1915429A Combinations of the peroxisome proliferator-activated receptor (ppar) activator fenofibrate with sterol absorption inhibitor ezetimibe for vascular indications |
| 02/20/2007 | US7179892 Humanized antibodies that recognize beta amyloid peptide |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179821 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain |
| 02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
| 02/20/2007 | US7179796 Protein phosphatase 1B; oligonucleotide of 8-50 nucleobases targeted to a nucleic acid molecule encoding PTP1B; specifically hybridizes with and inhibits the expression of PTP1B. |
| 02/20/2007 | US7179771 Composition |
| 02/20/2007 | US7179481 Increasing growth of epithelial cells in the female reproductive tract by administering to the vaginal cavity a retinoid or a carotenoid; treating vaginal dryness for example |
| 02/15/2007 | WO2005020934A3 Fsh glycosylation mutant |
| 02/15/2007 | WO2005013904A3 Sars nucleic acids, proteins, vaccines, and uses thereof |
| 02/15/2007 | WO2005000241A8 Compositons and methods for topical administration |
| 02/15/2007 | US20070037887 Blockade of mtor to prevent a hormonal adaptive response |
| 02/15/2007 | US20070037821 Nitrosated glutamic acid compounds, compositions and methods of use |
| 02/15/2007 | US20070037784 Ring structures C6.C6.C13N and C6.C6.C12NO |
| 02/15/2007 | US20070037773 Methods and compositions for treating flaviviruses and pestiviruses |
| 02/15/2007 | US20070037764 Method and antisense composition for selective inhibition of HIV infection in hematopoietic cells |
| 02/15/2007 | US20070037750 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 02/15/2007 | US20070037739 Compounds useful in coating stents to prevent and treat stenosis and restenosis |